Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Phathom Pharmaceuticals

Youtube Subscribe

...

Ticker: PHAT

Sector: Pharmaceuticals

Phathom Pharmaceuticals, Inc. focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB).
...
...
Extended Summary

Phathom Pharmaceuticals

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Related Results

...
March 09, 2024 17:27 (London Time)

Phathom Pharmaceuticals

Phathom Pharmaceuticals reported earnings per share of -$1.39.39. Management to host conference call on Thursday, March 7, 2024, at 8:30 am. ET. Pha…
Sector: Pharmaceuticals
Ticker: PHAT
Sentiment: 0.1531
MarketCap: 519,278,876.0
High: 9.38 Low: 8.57

Open: 9.17 Close: 8.88 Change: -0.29

Read more →
...
June 07, 2023 6:36 (London Time)

Phathom Pharmaceuticals

Wall Street analysts think 43.51% is the mean of analysts price targets for Phathom Pharmaceuticals. Institutional owners may ignore recent US$66m m…
Sector: Pharmaceuticals
Ticker: PHAT
Sentiment: -0.0772
MarketCap: 637,162,833.0
High: 11.81 Low: 11.52

Open: 11.71 Close: 11.64 Change: -0.07

Read more →
Search
Happening Now
Categories